Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy

Executive summary of the diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)

(2015) Francesc Gudiol et al.   ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

Pharmacokinetics of Daily Daptomycin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

(2013) Natascia Corti et al.   CHEMOTHERAPY

Clinical and pharmacokinetic considerations for the use of daptomycin in patients with Staphylococcus aureus bacteraemia and severe renal impairment

(2013) Ricardo L. Chaves et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Acute kidney injury: global health alert

(2013) Philip Kam Tao Li et al.   KIDNEY INTERNATIONAL

Experience with daptomycin daily dosing in ICU patients undergoing continuous renal replacement therapy

(2012) B. Preiswerk et al.   INFECTION

Daptomycin serum levels in critical patients undergoing continuous renal replacement

(2012) Marco Falcone et al.   JOURNAL OF CHEMOTHERAPY

Use of Pharmacokinetic and Pharmacodynamic Principles To Determine Optimal Administration of Daptomycin in Patients Receiving Standardized Thrice-Weekly Hemodialysis

(2011) Nimish Patel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of Dose De-Escalation and Escalation on Daptomycin's Pharmacodynamics against Clinical Methicillin-Resistant Staphylococcus aureus Isolates in anIn VitroModel

(2011) Celine Vidaillac et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Daptomycin pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy

(2011) Alain Rudiger et al.   CRITICAL CARE MEDICINE

Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?

(2011) Ian M. Gould et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Plasma pharmacokinetics of daptomycin in critically ill patients with renal failure and undergoing CVVHD

(2011) D. Khadzhynov et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Multiple-dose pharmacokinetics of daptomycin during continuous venovenous haemodiafiltration

(2011) J. M. Wenisch et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis

(2010) Sujata M. Bhavnani et al.   CLINICAL INFECTIOUS DISEASES

Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis

(2010) A. Mary Vilay et al.   CRITICAL CARE MEDICINE

The Impact of Continuous Renal Replacement Therapy on Drug Therapy

(2009) G M Susla   CLINICAL PHARMACOLOGY & THERAPEUTICS

Documento de consenso sobre el tratamiento de la bacteriemia y la endocarditis causada por Staphylococcus aureus resistente a la meticilina

(2009) Francisco Gudiol et al.   ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA